Search clinical trials for: Raloxifene

Total 83 results

Eli Lilly and Company

Completed

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Osteoporosis, Postmenopausal

Spain, United States, Taiwan, Italy, Argentina, Canada, France, Australia
Eli Lilly and Company

Completed

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Breast Cancer | Ovarian Cancer | Endometrial Cancer

United States
Eli Lilly and Company

Completed

Effects of Arzoxifene on Bone Mass and the Uterus

Postmenopausal Bone Loss

United States
Fundació Sant Joan de Déu
Stanley Medical Research Institute; Parc Sanitari Sant Joan de Déu; Hospital...

Completed

Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

Schizophrenia in Post Menopausal Women

Spain
Eli Lilly and Company

Completed

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Osteoporosis, Postmenopausal

United States
Eli Lilly and Company

Completed

A Study of Arzoxifene to Treat Korean Women With Osteoporosis

Osteoporosis

Korea, Republic of
Alvogen Korea

Completed

A Drug-drug Interaction Study of DP-R213

Healthy

Korea, Republic of
Iris Sommer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Ziekenhuis... and other collaborators

Completed

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder (RAPSODI)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis NOS

Netherlands
Eli Lilly and Company

Completed

Raloxifene Use for The Heart

Cardiovascular Diseases | Breast Neoplasms

United States
University of Wisconsin, Madison
National Institute on Aging (NIA)

Completed

Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

Alzheimer Disease

United States
Eli Lilly and Company

Completed

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer

Endometrial Cancer

United States
Chonbuk National University Hospital

Completed

Efficacy and Safety of Catechin High Contain Greentea Extract on Improvement of Cognitive Function

Cognitive Function

Korea, Republic of
The Alfred
National Health and Medical Research Council, Australia; Stanley Medical Research...

Completed

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia (SERM)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Australia
Toshihiko Kono

Unknown

The Effects of Seasonal Changes in Osteoporosis Treatment

Selective Estrogen Receptor Modulator (SERM)

Japan
Northwestern University
National Cancer Institute (NCI)

Completed

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Cancer

United States
Fundació Sant Joan de Déu

Completed

Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women

Schizophrenia

Spain
The Alfred
Monash University

Completed

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Australia
Tuen Mun Hospital
Eli Lilly and Company

Completed

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

Osteoporosis

China
Eli Lilly and Company

Completed

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

Endometriosis | Pelvic Pain

United States
Pfizer

Completed

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Osteoporosis, Postmenopausal
Alvogen Korea

Completed

DP-R213 Pharmacokinetics Study

Healthy
Ligand Pharmaceuticals

Completed

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss (CORAL)

Osteoporosis

United States
Eli Lilly and Company

Completed

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis (MORE)

Osteoporosis, Postmenopausal

Singapore, Canada, Mexico, Belgium, France, United States, Argentina, Australia, Austria, Czech Republic, Denmark, Finland, Germany, Hungary, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, United...
Dompé Farmaceutici S.p.A

Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

SARS CoV 2 Infection

France, Spain, Italy
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Hormone Therapy in Treating Women With Breast Cancer

Breast Cancer

United States
Eli Lilly and Company

Completed

EVA: Evista Alendronate Comparison

Osteoporosis

United States, Canada
Sara Saeidi Shahri

Completed

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

Rheumatoid Arthritis
Taichung Veterans General Hospital

Unknown

Osteoporosis Treatment in Post-menopausal Women

Depressive Syndrome

Taiwan
NSABP Foundation Inc
National Cancer Institute (NCI); Eli Lilly and Company; AstraZeneca

Completed

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Breast Cancer

United States, Canada, Puerto Rico
Stanford University
Indiana University; Kaiser Permanente; Southern Illinois University

Completed

Raloxifene for Women With Alzheimer's Disease

Alzheimer Disease

United States
University of Valencia

Completed

Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis

Postmenopausal Osteoporosis | Compliance

Spain
Sheba Medical Center

Unknown

Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder (RAL-S-01)

Schizophrenia | Schizoaffective Disorder

Israel, Romania
Brigham and Women's Hospital

Completed

Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data

Osteoporosis

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

Breast Cancer | Osteoporosis | Menopausal Symptoms

United States
Eli Lilly and Company

Completed

Long Term Effects of Raloxifene Treatment on Bone Quality

Osteoporosis, Post-Menopausal

United States, Mexico, Netherlands, Spain
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

LY353381 in Preventing Breast Cancer in Women With Hyperplasia

Breast Cancer

United States
Alvogen Korea

Completed

DP-R213 Phase 1 Pharmacokinetics Study

Healthy
National Cancer Institute (NCI)

Completed

Raloxifene in Preventing Breast Cancer in Premenopausal Women

Breast Cancer

United States
Eli Lilly and Company

Completed

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Osteoporosis, Post-Menopausal

United States
Institute of Cancer Research, United Kingdom

Completed

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

Breast Cancer

United Kingdom
Seth Lerner
AstraZeneca; Cytogen Corporation

Completed

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

Urinary Bladder Neoplasms

United States, Italy
Massachusetts General Hospital

Active, not recruiting

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Osteoporosis | Osteoporosis, Postmenopausal

United States
Bayer

Completed

3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

Osteopenia
The Alfred

Completed

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Australia
Eli Lilly and Company

Completed

2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

Germany
Eli Lilly and Company

Completed

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

United States
The Alfred
Stanley Medical Research Institute

Completed

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Australia
Milton S. Hershey Medical Center

Completed

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Breast Cancer

United States
Eli Lilly and Company

Completed

Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

Canada, United States

Search clinical trials for: Raloxifene

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations